Novartis' Sandoz Infringed On Pfizer Eye Drug Patents: Judge

Law360, Los Angeles (October 04, 2013, 9:07 PM ET) -- A New Jersey federal judge ruled Friday that Sandoz Inc. violated four patents owned by Pfizer Inc. and InSite Vision Inc. when it tried to bring to market a generic version of AzaSite azithromycin eye drops, which are used as a bacterial conjunctivitis treatment.

Judge Cooper said Friday that Sandoz, which is owned by Novartis AG, infringed two claims of U.S. Patent Number 6,861,411; four claims of U.S. Patent Number 6,239,113; two claims of U.S. Patent Number 6,569,443; and 10 claims of U.S. Patent Number 7,056,893....
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers

Required